I agree that this site is using cookies. You can find further informations here.
X
DiMasi, Joseph A.
58  results:
Search for persons X
?
1

Impact of regulatory system changes on the availability of ..:

Ge, Qianwei ; Xu, Lili ; DiMasi, Joseph A...
Nature Reviews Drug Discovery.  22 (2023)  5 - p. 344-345 , 2023
Link: https://doi.org/10.1038/..
 
?
2

Assessing the Financial Value of Decentralized Clinical Tri..:

DiMasi, Joseph A. ; Smith, Zachary ; Oakley-Girvan, Ingrid...
Therapeutic Innovation & Regulatory Science.  57 (2022)  2 - p. 209-219 , 2022
Link: https://doi.org/10.1007/..
 
?
3

Strategic, feasibility, economic, and cultural aspects of p..:

Burt, Tal ; Roffel, Ad F. ; Langer, Oliver..
Clinical and Translational Science.  15 (2022)  6 - p. 1355-1379 , 2022
Link: https://doi.org/10.1111/..
 
?
4

The Financial Benefits of Faster Development Times: Integra..:

DiMasi, Joseph A. ; Wilkinson, Michael
Therapeutic Innovation & Regulatory Science.  54 (2020)  6 - p. 1453-1460 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Development Times and Approval Success Rates for Drugs to T..:

DiMasi, Joseph A. ; Florez, Maria I. ; Stergiopoulos, Stella...
Clinical Pharmacology & Therapeutics.  107 (2019)  2 - p. 324-332 , 2019
Link: https://doi.org/10.1002/..
 
?
6

Assessing the Financial Value of Patient Engagement: A Quan..:

Levitan, Bennett ; Getz, Kenneth ; Eisenstein, Eric L....
Therapeutic Innovation & Regulatory Science.  52 (2018)  2 - p. 220-229 , 2018
Link: https://doi.org/10.1177/..
 
?
7

Assessing the Financial Benefits of Faster Development Time..:

DiMasi, Joseph A. ; Smith, Zachary ; Getz, Kenneth A.
Clinical Therapeutics.  40 (2018)  6 - p. 963-972 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Landscape of Innovation for Cardiovascular Pharmaceuticals:..:

Beierlein, Jennifer M. ; McNamee, Laura M. ; Walsh, Michael J....
Clinical Therapeutics.  39 (2017)  7 - p. 1409-1425.e20 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and..:

Stergiopoulos, Stella ; Calvert, Sara B ; Brown, Carrie A...
Clinical Infectious Diseases.  66 (2017)  1 - p. 72-80 , 2017
Link: https://doi.org/10.1093/..
 
?
10

Analysis of Review Times for Recent 505(b)(2) Applications:

Sakai, Sharon ; DiMasi, Joseph A. ; Getz, Kenneth A.
Therapeutic Innovation & Regulatory Science.  51 (2017)  5 - p. 651-656 , 2017
Link: https://doi.org/10.1177/..
 
?
11

Public- and Private-Sector Contributions to the Research an..:

Chakravarthy, Ranjana ; Cotter, Kristina ; DiMasi, Joseph..
Therapeutic Innovation & Regulatory Science.  50 (2016)  6 - p. 759-768 , 2016
Link: https://doi.org/10.1177/..
 
?
12

Innovation in the pharmaceutical industry: New estimates of..:

DiMasi, Joseph A. ; Grabowski, Henry G. ; Hansen, Ronald W.
Journal of Health Economics.  47 (2016)  - p. 20-33 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Cost Drivers of Hospital-Acquired Bacterial Pneumonia and V..:

Stergiopoulos, Stella ; Tenaerts, Pamela ; Getz, Kenneth...
Open Forum Infectious Diseases.  2 (2015)  suppl_1 - p. , 2015
Link: https://doi.org/10.1093/..
 
?
14

The Impact of Collaborative and Risk-Sharing Innovation App..:

DiMasi, Joseph A. ; Kim, Jennifer ; Getz, Kenneth A.
Therapeutic Innovation & Regulatory Science.  48 (2014)  4 - p. 482-487 , 2014
Link: https://doi.org/10.1177/..
 
?
15

Innovating by Developing New Uses of Already-Approved Drugs..:

DiMasi, Joseph A.
Clinical Therapeutics.  35 (2013)  6 - p. 808-818 , 2013
Link: https://doi.org/10.1016/..
 
1-15